Skip to main content

Table 2 Clinicopathological characteristics of gastric cancer patients from TCGA database

From: COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing

Clinicopathological Characteristics

Number of Gastric Cancer Patients (N = 443)

Age (years)

  ≤ 65

197 (44.5%)

  > 65

241 (54.4%)

 Unknown

5 (1.1%)

Gender

 Male

285 (64.3%)

 Female

158 (35.7%)

Grade

 G1

12 (2.7%)

 G2

159 (35.9%)

 G3

263 (59.4%)

 Unknown

9 (2.0%)

Stage

 Stage I

59 (13.3%)

 Stage II

130 (29.3%)

 Stage III

183 (41.3%)

 Stage IV

44 (9.9%)

 Unknown

27 (6.1%)

T classification

 T1

23 (5.2%)

 T2

93 (20.9%)

 T3

198 (44.7%)

 T4

119 (26.9%)

 Unknown

10 (2.3%)

N classification

 N0

132 (29.8%)

 N1

119 (26.9%)

 N2

85 (19.2%)

 N3

88 (19.9%)

 Unknown

19 (4.3%)

M classification

 M0

391 (88.3%)

 M1

30 (6.8%)

 Unknown

22 (4.9%)

Survival status

 Death

171 (38.6%)

 Survival

272 (61.4%)